Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study

Fig. 2

Boxplot of the number of reported NPS for each group, showing the median. *p < .05; **p < .01; ***p < .001. Whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles; outliers are represented by dots. The number of reported NPS in SCD subjects is higher compared to CO but significantly lower than in MCI and AD patients. CO reported significantly less NPS compared to SCD, MCI, and AD patients

Back to article page